Endurant Stent Graft System Post Approval Study (ENGAGE PAS)

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 178 participants.

Also called NCT01379222

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 178 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01379222
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01379222. Allocation not applicable; no masking; primary purpose treatment. Start 2011-08 (registry gives no type); primary completion 2017-12 (actual). Results posted on 2019-02-04.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Endurant Stent Graft System Post Approval Study (ENGAGE PAS)
Condition
Aortic Aneurysm, Abdominal
Intervention (Device)
Endurant Stent Graft System
Lead sponsor
Medtronic Cardiovascular (class: industry)
Collaborator
Duke Clinical Research Institute (class: other)

Record details

Record id
cardio:ct-nct01379222
Content hash
3c9d085cb795d81534f0568f36944ba6e8f08066965d60511a7e0cca54bb0e25